Hemorrhagic cystitis (HC) is a common and sometimes life-threatening complication of hemopoietic cell transplantation (HCT) occurring in 7-52% of transplant recipients. In this setting it is usually either related to the use of cyclophosphamide or to a viral infection (BK, JC viruses and adenovirus type 11). Treatment is based on hyperhydration, platelet and blood-cell transfusions, bladder irrigation and pain management. Where these measures have failed to control HC, numerous therapeutic approaches including surgery have been tried with poor success. We report two HCT patients with severe HC successfully treated with selective embolization of the vesical arteries. Bone Marrow Transplantation (2003) 31, 923-925.
plantation; selective embolization Hemorrhagic cystitis (HC) is a common and sometimes lifethreatening complication of hemopoietic cell transplantation (HCT) occurring in 7-52% of transplant recipients and contributing to mortality in 2-4%. 1, 2 Moreover, severe cystitis has been reported to occur in about 5% of HCT patients. 1 These patients develop gross hematuria accompanied by clot formation, severe pain and occasionally uncontrollable bleeding, urinary tract obstruction and renal failure. In this setting, patients are extremely debilitated, require prolonged hospitalization and may finally die.
Early HC is usually a complication of high-dose cyclophosphamide (CY) containing preparative regimens. The routine use of 2-mercaptoethane sulfonate sodium (mesna R ), hydration, and forced diuresis with or without bladder irrigation has largely eliminated early HC. 3 In contrast, late HC remains a continuing complication for any HCT and appears to be virally mediated (adenovirus types 11 and 21, polyomavirus BK and JC). 4 Other factors including radiation and drugs such as busulfan may also play a role in HC in patients undergoing HCT.
Numerous therapeutic approaches have been tried in HC without success. Since there is no effective therapy, medical management is based on intensive supportive treatment with red-cell and platelet transfusions, bladder irrigation and pain management. The use of bladder instillation of alum, prostaglandin, silver nitrate, phenol or formalin; surgical treatment with cystoscopy, cystotomy or cystectomy; administration of estrogens and hyperbaric oxigen treatment have been tried when previous treatments have failed, but with modest results. [5] [6] [7] [8] In patients where a viral etiology has been confirmed, antiviral treatment is indicated. However, there is no clear evidence that specific antiviral treatment resolves HC, although in some cases it can improve clinical symptoms. 9 We report two HCT patients with severe HC successfully treated with selective embolization of the vesical arteries.
Methods

Transcatheter embolization technique
The procedure was performed in an angiography room (Somaton Plus Siemens) under local anesthetic. In both patients, a retrograde catheterization of the femoral artery was carried out in order to perform digital angiography of the aorto-iliac sector. Subsequently, selective catheterization of the hypogastric arteries with a standard angiographic catheter Cobra II 4 F (Radiofocus, Glidecath, Terumo Corporation, Japan) was carried out to localize the vesical vessels and confirm their hypervascularization. Thereafter, superselective catheterization of the vesical arteries with a 3F microcatheter (Tracker catheter, Boston scientific) was achieved and embolization of these arteries was carried out with 355-500 mm of polyvinyl alcohol microparticles (Contour, Boston Scientific) with iodine contrast to ensure that slow flow was attained inside the arteries. After the vesical vessel embolization, a further hypogastric angiography was performed to assess the degree of occlusion of the vesical hypervascularization.
Case reports
Case 1
A 27-year-old male with refractory Hodgkin's disease received an allogeneic peripheral blood transplant from his HLA-identical brother. The patient was conditioned with CY 60 mg/kg once daily i.v. on days 1 and 2, followed by fractionated total body irradiation (12 Gy). Forced diuresis with vigorous hydration, urine alkalinization and mesna R was performed to avoid CY-induced HC. On day +40 he started to complain of increased urinary frequency, and pain on micturition, with gross hematuria and clots. Cultures of urine were negative, but the characteristic morphologic changes of polyomavirus BK in the urinary sediment were noted on electron microscopy. PCR for polyomavirus BK was also positive. There was no improvement in symptoms after several days of hydration, diuresis with continuous bladder irrigation and transfusion support. On day +85 selective embolization of the left vesical artery was performed. The right side was avoided to prevent harm to the genital vessels. HC improved immediately and the patient was discharged from hospital 1 week later with no recurrence of HC. At the present time, 8 months after treatment, he remains free of symptoms. ). Forced diuresis with vigorous hydration, urine alkcalinization and mesna R was performed according to standard guidelines. On day +28 suffering from thrombocytopenia, she developed severe HC. All urine cultures including viral isolation were negative. In spite of supportive measures with hydration, continuous bladder irrigation and daily red-blood cells and platelet transfusions, the condition of the patient worsened and on day +78 selective embolization of both vesical arteries was performed. From then on, the patient gradually improved, achieving complete recovery from HC 3 weeks later. After 3 1 2 years, she remains asymptomatic (Figures 1 and 2 ).
Discussion
The incidence of HC has declined over the last decades because of the improvement of transplantation procedures, as well as the enhancement of prophylactic measures for HC, especially those cases associated with toxicity of the conditioning regimen. 1 However, the absence of a specific and effective treatment makes severe HC a life-threatening complication, which is difficult to manage clinically. Surgical treatment is the ultimate therapeutic approach for this complication, but the inherent morbidity of a major surgical procedure in an extremely debilitated patient makes this approach very problematic. 5 Since some viral agents, such as adenovirus and polyomavirus, 4 have been demonstrated to play a pathogenic role in some patients, antiviral treatment with ribavirin, acyclovir, ganciclovir or cidofovir has been tried. There is no clear evidence that any patient with virus-related HC necessarily responds to specific antiviral treatments, although there are some reported cases. 9, 10 The use of hyperbaric oxygen treatment has been recently reported in the setting of HC in allogenic HCT. 8 However, the routine use of this approach is limited by its disadvantages in terms of availability and duration of the treatment.
Nowadays, percutaneous arterial embolization is an accepted approach for hemorrhages of a pelvic origin. Selective embolization of the vesical arteries is a frequent therapeutic procedure for those cases of HC associated with radiotherapy, tumors or traumatic events. [11] [12] [13] Moreover, this is in general an effective and safe procedure that can be repeated if necessary. What must be emphasized is the need to avoid bilateral embolization of the vesical Treatment of severe hemorrhagic cystitis E Giné et al arteries in males in order to prevent injury at the genital vessels. To the best of our knowledge, this treatment has not been used before for HC in the HCT setting. In summary, we report two cases of severe HC successfully treated by selective embolization of the vesical arteries. Both were unresponsive to prior treatment, and had severe thrombocytopenia needing platelet transfusions. A viral etiology was demonstrated in one of the cases and although no specific antiviral treatment was given, the patient was already receiving foscarnet for a suspected human herpesvirus-6 infection. Of note, both of the patients immediately improved after embolization and there was no recurrence of HC.
Finally, selective embolization of the vesical arteries should be considered as a treatment option in cases of severe HC refractory to conventional therapeutic measures. Despite the presence of thrombocytopenia, this approach, when carried out by an expert radiology team, is a safe and effective procedure.
